GO:0097527 necroptotic signaling pathway: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0097527 (necroptotic signaling pathway) describes the molecular cascade that triggers necroptosis, a regulated form of necrotic cell death dependent on RIPK1 and/or RIPK3 activation.
• The pathway is defined by the activation of receptor-interacting serine/threonine-protein kinases 1 and 3 (RIPK1/RIPK3) and culminates in the execution phase driven by MLKL.
• MLKL functions as a molecular switch: phosphorylation by RIPK3 induces a conformational change that exposes its execution domain, leading to membrane permeabilization.
• Necroptotic signaling is implicated in cancer, inflammatory bowel disease, Alzheimer's disease, and antitumor immunity, making it a high-value therapeutic target.
• Key regulators include ZBP1, CAMK2/CaMKII, p62, and autophagic UVRAG, which modulate RIPK1/RIPK3/MLKL activity in context-dependent manners.
• CRISPR-based models (knockout, point mutation, knock-in, overexpression) are essential for dissecting the causal roles of necroptotic pathway components in disease.
Description
The necroptotic signaling pathway (GO:0097527) is a biological process that triggers necroptotic cell death, a regulated form of necrosis with distinct molecular machinery. Unlike apoptosis, necroptosis depends on the activation of receptor-interacting serine/threonine-protein kinase 1 (RIPK1) and/or 3 (RIPK3), which assemble into a necrosome complex and phosphorylate the pseudokinase MLKL to execute membrane rupture. This pathway is critical for host defense, inflammation, and tissue homeostasis, and its dysregulation contributes to cancer, neurodegeneration, and inflammatory diseases. Researchers study GO:0097527 to understand how cells switch from survival to death and to identify therapeutic targets for diseases where necroptosis plays a causal role. The pathway is highly conserved and tightly regulated by post-translational modifications, protein-protein interactions, and autophagy-related proteins. This article provides a comprehensive overview of the necroptotic signaling pathway, its key genes, regulatory mechanisms, disease relevance, and experimental models for research.
necroptotic signaling pathway At A Glance
| GO ID | GO:0097527 |
|---|---|
| GO term | necroptotic signaling pathway |
| Ontology | biological_process |
| Synonym | necroptosis signaling; necroptosis signaling pathway; necroptotic signalling pathway; necroptotic signal transduction |
| Major function | Triggers necroptotic cell death via RIPK1/RIPK3 activation and MLKL execution |
| Key kinases | RIPK1, RIPK3 |
| Executioner | MLKL |
| Regulators | ZBP1, CAMK2/CaMKII, p62, UVRAG, autophagic machinery |
| Disease relevance | Cancer, inflammatory bowel disease, Alzheimer's disease, antitumor immunity |
What Is GO:0097527?
GO:0097527 (necroptotic signaling pathway) is defined as the series of molecular signals that triggers necroptotic death of a cell. The pathway begins with reception of a signal, is characterized by activation of receptor-interacting serine/threonine-protein kinase 1 and/or 3 (RIPK1/3, also called RIP1/3), and ends when the execution phase of necroptosis is triggered. This process is distinct from apoptosis and depends on the kinase activities of RIPK1 and RIPK3, which form a necrosome to activate MLKL.
Why Is necroptotic signaling pathway Important in Cell Biology?
The necroptotic signaling pathway is important because it represents a genetically programmed form of necrosis that can be harnessed for cancer therapy or blocked to prevent inflammatory and neurodegenerative diseases. Understanding its molecular steps provides opportunities for therapeutic intervention in conditions where necroptosis is dysregulated.
• Plays a key role in antitumor immunity and radiation-induced immune activation.
• Contributes to inflammatory bowel disease pathogenesis through a necroptotic-to-apoptotic signaling axis.
• Implicated in Alzheimer's disease via TNF-α-dependent neuronal necroptosis regulated by RIPK1-p62 and autophagic UVRAG.
• Represents a target for cancer therapy, as necroptosis can overcome apoptosis resistance.
• Regulated by metabolic stress such as short-term starvation through CAMK2/CaMKII activation of MLKL.
• Involves a molecular switch mechanism in MLKL that is critical for execution of necroptosis.
• Evolutionarily conserved and relevant to host defense and tissue homeostasis.
• Knockout mouse models have elucidated the roles of RIPK1, RIPK3, and MLKL in development and disease.
• Offers opportunities for CRISPR-based screens to identify novel regulators.
• Potential biomarker and therapeutic target in inflammatory and neurodegenerative diseases.
What Happens During necroptotic signaling pathway?
Initiation and Receptor Engagement
In simple terms: The pathway starts when a death signal, such as TNF-α, binds to its receptor and triggers a series of protein interactions.
Necroptotic signaling is initiated by various stimuli, including TNF-α, Fas ligand, and viral infections, which activate receptor-interacting proteins. Upon TNF-α binding to TNFR1, the receptor recruits RIPK1 through its death domain, leading to the formation of a complex that can either promote survival or switch to necroptosis depending on cellular context. This step is tightly regulated by ubiquitination and phosphorylation events that determine cell fate.
Activation of RIPK1 and RIPK3
In simple terms: RIPK1 and RIPK3 are kinases that become activated and interact with each other to form a necrosome.
Activation of RIPK1 and/or RIPK3 is the hallmark of the necroptotic signaling pathway. RIPK1 autophosphorylation and its interaction with RIPK3 via the RIP homotypic interaction motif (RHIM) lead to the formation of the necrosome, a cytosolic complex where RIPK3 phosphorylates MLKL. This step is essential for the execution of necroptosis and is regulated by proteins such as ZBP1, which can activate RIPK3 in response to viral nucleic acids.
MLKL Activation and Execution
In simple terms: MLKL is the executioner protein that, once activated by RIPK3, moves to the cell membrane and punches holes, causing cell death.
MLKL is phosphorylated by RIPK3 at specific residues, inducing a conformational change that exposes its four-helix bundle domain, which translocates to the plasma membrane and permeabilizes it. This molecular switch mechanism is critical for necroptotic execution and is regulated by additional factors such as CAMK2/CaMKII under starvation conditions. The membrane disruption leads to release of damage-associated molecular patterns and cell lysis.
Regulation by Autophagy and Metabolic Stress
In simple terms: Other cellular processes like autophagy and starvation can influence whether necroptosis proceeds.
Autophagic proteins such as UVRAG and p62 modulate necroptotic signaling by interacting with RIPK1 and affecting its stability or activity. Short-term starvation activates CAMK2/CaMKII, which phosphorylates MLKL to facilitate autophagic flux and potentially modulate necroptosis. These regulatory layers ensure that necroptosis is tightly controlled and integrated with cellular stress responses.
Key Genes Involved in GO:0097527 necroptotic signaling pathway
The following genes and proteins are central to the necroptotic signaling pathway, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| RIPK1 | Serine/threonine kinase; initiates necrosome formation | Key target for knockout and point mutation studies |
| RIPK3 | Kinase that phosphorylates MLKL; essential for necroptosis | Central to pathway activation; knockout models available |
| MLKL | Executioner pseudokinase; permeabilizes membranes | Molecular switch mechanism; target for knock-in and overexpression |
| ZBP1 | Sensors viral nucleic acids; activates RIPK3 | Links innate immunity to necroptosis |
| CAMK2/CaMKII | Kinase that activates MLKL under starvation | Regulates autophagic flux and necroptosis |
| p62/SQSTM1 | Autophagy receptor; interacts with RIPK1 | Modulates neuronal necroptosis in Alzheimer's disease |
| UVRAG | Autophagic protein; coordinates with RIPK1-p62 | Regulates necroptosis in neurodegeneration |
| TNFR1 | Receptor for TNF-α; initiates signaling | Upstream activator of necroptosis |
| TNF-α | Cytokine that triggers necroptosis | Key stimulus in inflammatory diseases |
| STING | Activates immune response downstream of necroptosis | Links necroptosis to antitumor immunity |
| Caspase-8 | Apoptotic protease; inhibits necroptosis | Crosstalk between apoptosis and necroptosis |
| FADD | Adaptor protein; recruits caspase-8 | Regulates cell death decision |
| TRADD | Adaptor protein; mediates TNFR1 signaling | Involved in complex I formation |
| cIAP1/2 | Ubiquitin ligases; regulate RIPK1 stability | Determine survival vs. death |
| CYLD | Deubiquitinase; promotes necroptosis | Regulates RIPK1 ubiquitination |
| A20 | Ubiquitin-editing enzyme; inhibits necroptosis | Negative regulator of NF-κB and necroptosis |
| TAK1 | Kinase; inhibits necroptosis | Regulates RIPK1 activity |
| NEMO | Regulatory subunit of IKK; modulates necroptosis | Links NF-κB to necroptosis |
How Is necroptotic signaling pathway Regulated?
The necroptotic signaling pathway is regulated at multiple levels, including ubiquitination, phosphorylation, and autophagy. cIAP1/2 and CYLD control RIPK1 ubiquitination status, determining whether it activates NF-κB or necroptosis. Caspase-8 acts as a negative regulator by cleaving RIPK1/RIPK3, and its inhibition promotes necroptosis. Autophagic proteins such as p62 and UVRAG modulate RIPK1 stability and activity in neurons. Metabolic stress via CAMK2/CaMKII can activate MLKL to facilitate autophagic flux, adding another layer of regulation. ZBP1 senses viral nucleic acids and activates RIPK3, linking innate immune sensing to necroptosis.
necroptotic signaling pathway and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| RIPK1 | Alzheimer's disease, IBD | Knockout and point mutation in neuronal and intestinal cells |
| RIPK3 | Cancer, inflammation | Knockout mice and cell lines |
| MLKL | Cancer, IBD | Knock-in and overexpression models |
| ZBP1 | Antitumor immunity | Knockout and tagged knock-in for imaging |
| CAMK2/CaMKII | Metabolic stress, autophagy | Point mutation and knockout |
Necroptosis in Cancer
Necroptosis plays a dual role in cancer, acting as a tumor suppressor mechanism in some contexts while promoting tumor progression and metastasis in others. Activation of necroptotic signaling can enhance antitumor immunity, as shown by ZBP1-MLKL signaling potentiating radiation-induced antitumor immunity via STING pathway activation. Targeting necroptosis is a promising strategy for cancer therapy, particularly for apoptosis-resistant tumors.
Necroptosis in Inflammatory Bowel Disease
A necroptotic-to-apoptotic signaling axis underlies inflammatory bowel disease (IBD), where dysregulated necroptosis contributes to intestinal inflammation and tissue damage. Modulating this pathway may offer therapeutic benefits for IBD patients.
Necroptosis in Alzheimer's Disease
TNF-α-dependent neuronal necroptosis is regulated in Alzheimer's disease by the coordination of RIPK1-p62 complex with autophagic UVRAG. This suggests that targeting necroptotic signaling could be neuroprotective in Alzheimer's disease.
From necroptotic signaling pathway-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does RIPK1 kinase activity drive necroptosis in neurons? | RIPK1 kinase-dead knock-in mice or cells |
| What is the role of MLKL phosphorylation in execution? | MLKL point mutants (phospho-deficient) |
| How does ZBP1 activate necroptosis in tumors? | ZBP1 knockout and overexpression in cancer cells |
| Does CAMK2 regulate MLKL under starvation? | CAMK2 knockout or point mutation |
| Can necroptosis be targeted in IBD? | RIPK3 knockout intestinal organoids |
| What is the impact of p62-UVRAG interaction? | p62 knockout and UVRAG overexpression |
How to Study the necroptotic signaling pathway Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR knockout screen | Gene essentiality for necroptosis | Identify novel regulators |
| Phosphoproteomics | Phosphorylation sites on RIPK1/3 and MLKL | Map signaling events |
| Live-cell imaging | Necrosome formation and MLKL translocation | Study molecular switch |
| Knockout mouse models | Physiological role of necroptosis genes | Validate in vivo relevance |
| RNA-seq | Transcriptional changes during necroptosis | Identify pathway crosstalk |
| Immunoprecipitation | Protein-protein interactions (e.g., RIPK1-p62) | Study complex formation |
| Autophagic flux assay | Autophagy induction by MLKL | Link necroptosis to autophagy |
| STING reporter assay | Activation of innate immune signaling | Measure antitumor immunity |
CRISPR Screens for Necroptosis Regulators
Genome-wide CRISPR knockout screens can identify novel genes that regulate necroptotic signaling, as demonstrated in cancer biology studies. These screens use libraries targeting thousands of genes and select for cells that survive or die under necroptosis-inducing conditions.
Phosphoproteomics and Proteomics
Mass spectrometry-based proteomics can map phosphorylation events on RIPK1, RIPK3, and MLKL during necroptosis, revealing regulatory sites and signaling networks. This approach helps identify kinase substrates and crosstalk with other pathways.
Live-Cell Imaging of Necroptosis
Fluorescently tagged MLKL or RIPK3 can be used to visualize necrosome formation and membrane translocation in real time, providing insights into the molecular switch mechanism. Imaging is often combined with viability dyes to correlate signaling with cell death.
Knockout Mouse Models
Knockout mice for Ripk1, Ripk3, or Mlkl have been instrumental in defining the physiological roles of necroptosis in development and disease. These models help validate findings from cell-based studies.
How CRISPR Can Be Used to Study GO:0097527 necroptotic signaling pathway
Knockout
CRISPR knockout of RIPK1, RIPK3, or MLKL is widely used to confirm their essential roles in necroptotic signaling. Knockout cell lines and mice have demonstrated that loss of these genes abolishes necroptosis in response to various stimuli.
Point Mutation
Point mutations, such as kinase-dead RIPK1 or phospho-deficient MLKL, allow researchers to dissect specific residues required for necroptotic signaling without completely eliminating protein expression. These models are critical for understanding the molecular switch mechanism of MLKL.
Knock-in
Knock-in of tagged versions of RIPK3 or MLKL (e.g., GFP or HA tags) enables visualization and biochemical isolation of necrosome components. Knock-in of disease-associated mutations can model human pathologies.
Overexpression
Overexpression of necroptotic pathway components, such as MLKL or ZBP1, can sensitize cells to necroptosis and is used to study pathway activation and antitumor immunity. Overexpression models help identify downstream effects and potential therapeutic targets.
How EDITGENE Supports necroptotic signaling pathway Research
Researchers studying necroptotic signaling pathway-related genes often need to determine whether a candidate gene is causally involved in necroptosis or simply correlated with the process. EDITGENE provides CRISPR-based services to generate precise cellular and animal models for such investigations.
Contact EDITGENE today to design your custom CRISPR model for necroptotic signaling pathway research.
Frequently Asked Questions About necroptotic signaling pathway
What is the necroptotic signaling pathway?
The necroptotic signaling pathway (GO:0097527) is a series of molecular signals that triggers necroptotic cell death, characterized by activation of RIPK1 and/or RIPK3 and ending with MLKL execution.
What genes are involved in necroptotic signaling pathway?
Key genes include RIPK1, RIPK3, MLKL, ZBP1, CAMK2, p62, UVRAG, and TNFR1, among others.
How does necroptosis differ from apoptosis?
Necroptosis is a regulated form of necrosis dependent on RIPK1/RIPK3/MLKL, whereas apoptosis relies on caspase activation and is non-lytic.
What is the role of MLKL in necroptosis?
MLKL is the executioner pseudokinase that, upon phosphorylation by RIPK3, undergoes a conformational switch to permeabilize membranes and cause cell death.
How is necroptotic signaling regulated?
It is regulated by ubiquitination, phosphorylation, caspase-8 cleavage, and autophagy-related proteins such as p62 and UVRAG.
What diseases are associated with necroptosis?
Necroptosis is implicated in cancer, inflammatory bowel disease, Alzheimer's disease, and antitumor immunity.
Can CRISPR be used to study necroptotic signaling?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are widely used to dissect the pathway.
What is the necrosome?
The necrosome is a cytosolic complex formed by RIPK1 and RIPK3 that phosphorylates MLKL to execute necroptosis.
How does ZBP1 activate necroptosis?
ZBP1 senses viral nucleic acids and activates RIPK3, linking innate immune sensing to necroptotic signaling.
What experimental models are available for necroptosis research?
Models include knockout mice, point mutant cell lines, tagged knock-in, overexpression systems, and CRISPR screens.
Conclusion
The necroptotic signaling pathway (GO:0097527) is a critical biological process with profound implications for cancer, inflammation, and neurodegeneration. Understanding its molecular mechanisms, key genes, and regulatory networks provides a foundation for therapeutic development. CRISPR-based models and screening approaches are indispensable tools for advancing this field.
References
- 1. Yang Y et al.. 2021. ZBP1-MLKL necroptotic signaling potentiates radiation-induced antitumor immunity via intratumoral STING pathway activation.. Sci Adv 7(41):eabf6290 PMID: 34613770
- 2. Belizário J et al.. 2015. Necroptotic Cell Death Signaling and Execution Pathway: Lessons from Knockout Mice.. Mediators Inflamm 2015:128076 PMID: 26491219
- 3. Gong Y et al.. 2019. The role of necroptosis in cancer biology and therapy.. Mol Cancer 18(1):100 PMID: 31122251
- 4. Xu C et al.. 2021. TNF-α-dependent neuronal necroptosis regulated in Alzheimer's disease by coordination of RIPK1-p62 complex with autophagic UVRAG.. Theranostics 11(19):9452-9469 PMID: 34646380
- 5. Vince JE. 2017. Necroptotic death signaling: evolution, mechanisms and disease relevance.. Immunol Cell Biol 95(2):129-130 PMID: 28194028
- 6. Zhan Q et al.. 2022. CAMK2/CaMKII activates MLKL in short-term starvation to facilitate autophagic flux.. Autophagy 18(4):726-744 PMID: 34282994
- 7. Pang J et al.. 2026. A necroptotic-to-apoptotic signaling axis underlies inflammatory bowel disease.. Science 393(6814):eaeh7112 PMID: 42658927
- 8. Murphy JM et al.. 2013. The pseudokinase MLKL mediates necroptosis via a molecular switch mechanism.. Immunity 39(3):443-53 PMID: 24012422
